Profitelligence Profitelligence · Filing Ledger Open GILD research →

Form 8-K · Current Report · Filed 2025-03-12

Gilead Sciences Announces Departure of CAO and Interim Replacement

Gilead Sciences, Inc. announced on March 12, 2025, the departure of Sandra Patterson, the Company's Senior Vice President, Corporate Controller, and Chief Accounting Officer. The Board of Directors has appointed Diane E. Wilfong as the interim Corporate Controller and Chief Accounting Officer, effective immediately. Ms. Wilfong previously held the same position from February 2016 to March 2023 and has extensive experience in similar roles at other companies.

Filer
Gilead Sciences Inc. GILD · NASDAQ
Filed
Accession
0001104659-25-023012
CIK
0000882095
Signal
Medium impactHealthcare

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

CAO Resignation New CAO Appointed

Market reaction

Close before filing

$114.43

Next session

-0.9%

Since filing

+13.8%

Latest close

$130.21

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from GILD reporting the same item, with the next session's move:

About Gilead Sciences Inc.

Gilead Sciences Inc. is a biopharmaceutical company that focuses on researching, developing, and commercializing innovative medicines in areas of unmet medical need. It is globally recognized for its distinguished work, particularly in the treatment of HIV, liver diseases such as hepatitis B and C, and various forms of cancer. The company's portfolio includes groundbreaking antiviral therapies and a robust pipeline of investigational drugs. Headquartered in Foster City, California, Gilead Sciences Inc. significantly contributes to the healthcare sector by extending the lives of patients with serious illnesses worldwide. Through strategic partnerships and continuous innovation, Gilead remains at the forefront of modern medicine, enhancing its role in the global pharmaceutical market.

Exchange NASDAQ Industry Drug Manufacturers - General Company website ↗

Never miss another GILD filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts